 DEER PARK, Ill., March 16, 2021 GLOBE NEWSWIRE -- Eton Pharmaceuticals, Inc Nasdaq: ETON, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on business progress. 